getting semaglutide from canada approves generic Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Canada approves first generic semaglutide

Dietary fatty acid composition affects the apparent digestibility of algal carotenoids in diets for Atlantic salmon, Salmo salar

Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (under the brand name Zepbound)

Realistic Expectations Learn why every patients timeline is unique and why treatment decisions should always remain individualized

Expert advice becomes essential, not optional when dealing with them

Vitamin D and the thyroid: a critical review of the current evidence

2026 Formulary Exclusions Drug List: Drugs not covered and their covered alternatives for the Standard Control